Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 21 - 30 of about 122   

Articles published

GSK 1,451.53 -0.97 (-0.07%)
price chart
Have GlaxoSmithKline plc, Diageo plc and WM Morrison plc finally turned the ...
Pharmaceutical giant GlaxoSmithKline (LSE: GSK) is seen as one of the safest bets on the FTSE 100 but it has hasn't been a winning one in recent years.
GlaxoSmithKline plc (NYSE:GSK) Resolves Bexsero Shortage
After a global shortage, meningitis B vaccine Bexsero will finally be restocked in the UK by June - GlaxoSmithKline plc (NYSE:GSK) revealed.
Novartis AG (NYSE:NVS) Ultibro Is Performing Better Than GlaxoSmithKline plc ...
The New England Journal of Medicine published data revealing that the Novartis AG (NYSE:NVS)'s Ultibro Breezhaler is doing better than the GlaxoSmithKline plc (NYSE:GSK)'s Seretide. Seretide also is known as Advair in the United States, and prevents ...
HC Stocks Broker Alerts: Biodel Inc (NASDAQ:BIOD), GlaxoSmithKline plc (ADR ...
Shares of Biodel Inc (NASDAQ:BIOD) ended Friday session in red amid volatile trading. The shares closed down -0.026 points or -7.38% at $0.333 with 2.12 million shares getting traded.
GlaxoSmithKline plc 13.5% Potential Upside Indicated by Barclays Capital
GlaxoSmithKline plc using EPIC/TICKER code LON:GSK had its stock rating noted as 'Reiterates' with the recommendation being set at 'OVERWEIGHT' today by analysts at Barclays Capital.
GlaxoSmithKline plc (GSK) Stock Rating Reaffirmed by Citigroup Inc.  Web Breaking News
Citigroup Indicates Potential 7.19% Increase In Shares Of GlaxoSmithKline PLC  Risers & Fallers
Energy Recovery, Inc. (NASDAQ:ERII) rose 2.02%: GlaxoSmithKline plc (NYSE:GSK ...
Law Offices of Howard G. Smith announces an investigation on behalf of investors of Energy Recovery, Inc. (NASDAQ:ERII) concerning the Company and its officers' possible violations of federal securities laws.
GlaxoSmithKline plc 4% Potential Decrease Indicated by Cantor Fitzgerald
GlaxoSmithKline plc with EPIC/TICKER LON:GSK had its stock rating noted as 'Reiterates' with the recommendation being set at 'HOLD' this morning by analysts at Cantor Fitzgerald.
Analyst's Report Recap: GlaxoSmithKline plc (ADR) (NYSE:GSK)
The mean price target for the shares of GlaxoSmithKline plc (ADR) (NYSE:GSK)is at $47.00 while the highest price target suggested by the analysts is $49.00 and low price target is $44.00.
Cowen and Company Lowers GlaxoSmithKline plc (GSK) to Market Perform  The Cerbat Gem
Healthcare Stock's Latest Update : Ionis Pharmaceuticals Inc (NASDAQ:IONS ...
In most recently trading session on 5/26/2016, GlaxoSmithKline PLC (NYSE:GSK) dropped -0.07% while traded on 1.85 million shares versus it's an average volume of 3.23 million shares.
Cowen Downgrades Ionis After Thrombocytopenia Issues  Benzinga
GlaxoSmithKline plc (NYSE:GSK) Decides Against Beginning A Phase-Three Study ...  Street Wise Report (press release) (blog)
GlaxoSmithKline PLC (NYSE:GSK) Quarterly EPS From Continuing Operations Stands ...
GlaxoSmithKline PLC (NYSE:GSK) diluted EPS from parent firm came at $5.2689 for the year ended 2016-03-31. For the quarter ended 2016-03-31 it came at $5.2689.
Current Price Targets For GlaxoSmithKline PLC (NYSE:GSK)  Risers & Fallers
Today GlaxoSmithKline plc (ADR) Stock Crashes. What To Expect?  The Post